Código QR (código de barras bidimensional)

Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia

Background & Aims. This paper presents the results of the observational study of ibrutinib in patients with chronic lymphocytic leukemia (CLL), conducted in SP Botkin Municipal Clinical Hospital. The main objective was the analysis of complications of ibrutinib and identification of factors, influen...

ver descrição completa

Na minha lista:
Principais autores: EA Nikitin, EA Dmitrieva, MA Panteleev, EI Emelina, VL Ivanova, YuB Kochkareva, EG Arshanskaya, IE Lazarev, EE Markova, LA Mukha, NG Novitskaya, MM Pankrashkina, VV Glazunova, AV Shubina, SA Chernysh, NK Khuazheva, EV Naumova, SA Lugovskaya, ME Pochtar’, TN Obukhova, OYu Vinogradova, GE Gendlin, VV Ptushkin
Formato: Artigo
Idioma:Russo
Publicado em: Practical Medicine Publishing House 2017-07-01
coleção:Клиническая онкогематология
Assuntos:
chronic lymphocytic leukemia
del 17p
TP53
refractory CLL
ibrutinib
bleeding
atrial fibrillation
Acesso em linha:http://bloodjournal.ru/wp-content/uploads/2017/09/1.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados